We are live on ! Find out more
BCTXL

BriaCell Therapeutics Warrant
BCTXL

15 hedge funds and large institutions have $3.7M invested in BriaCell Therapeutics Warrant in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.11M
2
+$568K
3
+$403K
4
CCC
Cable Car Capital
California
+$341K
5
EAM
Empery Asset Management
New York
+$318K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$1.05M
AC
2
Armistice Capital
New York
$553K
SM
3
Sabby Management
Florida
$392K
CCC
4
Cable Car Capital
California
$332K
EAM
5
Empery Asset Management
New York
$309K
HCM
6
Heights Capital Management
California
$300K
MA
7
MYDA Advisors
New York
$206K
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$125K
WAM
9
Warberg Asset Management
Illinois
$118K
CS
10
Clear Street
New York
$107K
BFM
11
Boothbay Fund Management
New York
$83.8K
IAM
12
Iridian Asset Management
Connecticut
$67K
LCM
13
LuminArx Capital Management
New York
$25.8K
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$23.9K
FIA
15
FNY Investment Advisers
New York
$7K